NCT01706900

Brief Summary

Incubator temperature is one of the most precious variables in IVF labs. When the IVF started, almost all incubator temperatures were set at 37 degrees which mimic in vivo conditions. Some authors speculated that gametes and early embryos might need low temperatures that provide quieter metabolism. We decide to compare Embryo culture at 37 degree or slightly lower 36.5 degree and extensively investigate to find which is better to crucially introduce a solid evidence through this RCT.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 10, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 15, 2012

Completed
17 days until next milestone

Study Start

First participant enrolled

November 1, 2012

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

June 29, 2016

Status Verified

June 1, 2016

Enrollment Period

3.1 years

First QC Date

October 10, 2012

Last Update Submit

June 28, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fetal heart beat rate

    Compare the fetal heart beat rate between the 2 study arms in the first 3 months following Embryo Transfer.

    3 months

Secondary Outcomes (5)

  • Pregnancy rate

    one month

  • Top quality embryos Day3

    one week

  • blastocyst formation rate

    one week

  • Top quality blastocyst

    one week

  • Implantation rate

    one month

Other Outcomes (1)

  • Cleavage rate on day 3

    one month

Study Arms (2)

Incubator Temp 37 degree

PLACEBO COMPARATOR

We will set incubator Temp to 37 degree as the routine embryo culture Temp since 1978 as the placebo arm.

Other: Incubator Temp 37 degree

Incubator Temp set to 36.5 degree

EXPERIMENTAL

We will set incubator Temp to 36.5 so we can assess the outcome and compare the results with the placebo group.

Other: Incubator Temp set to 36.5 degree

Interventions

We will set incubator Temp to 36.5 so we can assess the outcome and compare the results with the placebo group.

Incubator Temp set to 36.5 degree

We will set incubator Temp to 37 degree as the routine embryo culture Temp since 1978 as the placebo arm.

Incubator Temp 37 degree

Eligibility Criteria

Age18 Years - 33 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women aged ≤ 33 years
  • BMI ≤ 33
  • Normal responder ( ≥ 8 MII )
  • Fresh cycle
  • First attempt (or with previous successful attempt)
  • Normal or mild oligoasthenoteratozoospermia

You may not qualify if:

  • Testicular sperm
  • \< 8 MIII collected
  • Difficult transfer cycle
  • endometriotic patients
  • Poor Endometrium \< 8mm diameter at OPU

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IbnSina IVF Center, IbnSina Hospital

Sohag, Sohag Governorate, 12345, Egypt

Location

Study Officials

  • Muhammad F. Abdel-Raheem, Lab Director

    IbnSina IVF Center

    PRINCIPAL INVESTIGATOR
  • Mohamed Y. Abdel-Rahman, M.D.

    IbnSina IVF center

    PRINCIPAL INVESTIGATOR
  • Hesham A. Kasem, Gynaecologist

    IbnSina IVF Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
IVF Laboratory Director

Study Record Dates

First Submitted

October 10, 2012

First Posted

October 15, 2012

Study Start

November 1, 2012

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

June 29, 2016

Record last verified: 2016-06

Locations